|Institution:||Queen's University Belfast|
|Term:||until 31st August 2021|
|Salary:||£33,199 to £39,610|
|Line 1:||Queen's University Belfast|
The Centre for Cancer Research and Cell Biology (CCRCB) is the beating heart of a comprehensive cancer research programme in Belfast, focused on accelerating the delivery of scientific discovery to clinical application. CCRCB is the research hub of the Belfast ECMC and the Belfast Experimental Cancer Medicine Centre (ECMC), operating in partnership with the Belfast Health and Social Care Trust.
Our integrated clinical and scientific programmes address clinically unmet needs. Our principal objective is to promote evidence-based, innovative clinical trials in order to underpin improved patient outcomes in high incidence solid tumours of Gastro-Intestinal, Prostatic, Breast and Ovarian origin, and in specific Blood Cancers. Our unifying research theme is to develop translational outputs, in the form of biomarkers and/or novel therapeutic strategies that enable our Centre to be at the forefront of personalised cancer medicine in these prevalent diseases.
The Centre for Cancer Research and Cell Biology is seeking to appoint a Research Fellow to work on the My BLOCk (Myeloid Blood Cancer) funded by the Leukaemia & Lymphoma NI. The project will undertake mutational screening using next-generation sequencing (NGS) to link the mutations with in-vitro high through-put drug screening in order to map the relationship between mutations and drug responses with the aim of moving towards the rapid identification of therapies for patients with myeloid blood cancers.
As a Research Fellow you will be focused on integrating mutations analysis, by NGS with the drug responses patients with myeloid blood cancers (My BLOCk). The My BLOCk initiative is funded by Leukaemia & Lymphoma NI (LLNI) and will involve interaction with scientists within the Blood Cancer group within CCRCB and the Haematology Laboratory within the Belfast City Hospital.
Informal enquiries may be directed to Dr Katrina Lappin via email to email@example.com